New Key Statistics Module, Z-Score and F-Score
GREY:CDLYY Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | 5,074.32 |
| P/E(ttm) | 28.17 |
| PE Ratio without NRI | 28.24 |
| Forward PE Ratio | -- |
| Price/Book | 5.45 |
| Price/Sales | 5.72 |
| Price/Free Cash Flow | 46.84 |
| Price/Owner Earnings | 33.16 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.04 |
| 10-y EBITDA Growth Rate % | 11.80 |
| 5-y EBITDA Growth Rate % | 12.20 |
| y-y EBITDA Growth Rate % | 64.90 |
| EV-to-EBIT | 21.86 |
| EV-to-EBITDA | 18.91 |
| PEG | 2.31 |
| Shares Outstanding M | 2,047.49 |
| Net Margin (%) | 20.29 |
| Operating Margin % | 23.86 |
| Pre-tax Margin (%) | 25.28 |
| Quick Ratio | 1.51 |
| Current Ratio | 2.15 |
| ROA % (ttm) | 14.31 |
| ROE % (ttm) | 20.65 |
| ROIC % (ttm) | 15.80 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.49 |
CDLYY Number of Guru Trades
CDLYY Volume of Guru Trades
Gurus Latest Trades with GREY:CDLYY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:CDLYY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zydus Lifesciences Ltd Insider Transactions
No Available Data
News about GREY:CDLYY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers